Migraines are a type of headache that can cause intense pain on one or both sides of the head. They often occur with other symptoms, such as sensitivity to light and noise, nausea, and visual disturbances. Migraines are more common in women than in men and typically develop in early adulthood. The exact cause of migraines isn't completely understood. The scientific consensus is that they are caused by a combination of genetic, environmental, and lifestyle factors. Certain environmental triggers can increase the risk of migraines, such as stress, certain foods or drinks, missed meals, changes in sleep patterns, and changes in the weather. The most common type of migraine is a migraine with aura, which is characterized by a visual disturbance, such as blind spots, sensitivity to light, blind spots, and/or visual hallucinations. About 20%-30% of migraines involve an aura. Migraine treatment options include lifestyle changes (such as reducing stress levels, avoiding certain foods and drinks, and maintaining regular sleep patterns), medications, and natural alternatives such as acupuncture, yoga, and massage. Certain dietary changes may also help prevent or reduce migraine headaches. A GP is the best person to diagnose migraines and recommend appropriate treatments. It is important to see a GP if you think you might be suffering from migraines, as other conditions can cause similar symptoms. It is also important to seek help if your headaches become more frequent and/or more intense.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom